The evidence-based indications of 0.1% topical tacrolimus in ophthalmology: a scoping review
0.1% tacrolimus is effective and safe for a wide spectrum of eye diseases involving the anterior segment and adnexa. Not only does 0.1% topical tacrolimus spare patients from the side effects of chronic topical corticosteroid use but it also emerges as an option for patients inadequately managed by other immunosuppressants, highlighting the growing significance of 0.1% tacrolimus in ophthalmic practice.
Authors
- Rachel W. Y. Tsui
- Jacqueline W. T. Chan
- Ke Liu
- Patricia Dorothy Lam
- Julia Y. Y. Chan
Institutions
- Chinese University of Hong Kong (HK)
- Hong Kong Eye Hospital (CN)
Publication Details
- Journal
- Therapeutic Advances in Ophthalmology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1177/25158414251405461
- Primary Topic
- Ocular Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00